跳至主要内容
临床试验/NCT03125031
NCT03125031已完成不适用

Comparison of Noninvasive Hemoglobin Disposable Sensors

Masimo Corporation2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2014年7月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
2
主要终点
Accuracy of Noninvasive Sensors by Arms Calculation

研究概览

简要总结

In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of two noninvasive hemoglobin sensors will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • 18-40 years of age
  • Weight of at least 110 lbs and less than 250 lbs for subjects under 6 feet tall.
  • Physical status of ASA I of II
  • Able to read and communicate in English
  • Has signed written informed consent
  • Female, non pregnant.

排除标准

  • Age less than 18 yrs and greater than 40 years
  • If the Warming and cooling subjects have open cuts of skin abrasions on their extremities they will be excluded because alcohol spray may be painful.
  • Weight of less than 110 lbs or more than 250 lbs if the subject is less than 6 feet tall.
  • Hemoglobin less than 11 g/dL
  • ASA physical status of III. IV, V.
  • Subject has known drug or alcohol abuse
  • Subject has skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails.
  • Subject has experienced a head injury with loss of consciousness within the last year.
  • Subject has known neurological and psychiatric disorder that interferes with the subjects' level of consciousness.
  • Known or concurrent chronic usage of psychoactive or anticonvulsive drugs within the last 90 days, or any use in the last 7 day (i.e. tricyclic antidepressants, MAO inhibitors, Lithum, neuroleptics, anxiolytics or antipsychotics, except SSRIs).
  • Subject has any medical condition which in the judgment of the investigator, renders them inappropriate for participation in this study, such as Reynauds Syndrome.
  • Systolic BP >140 mmHg or Diastolic BP > 100 mmHg.
  • Baseline heart rate < 50 bpm.
  • Inability to tolerate sitting still or minimal movement for up to 90 minutes
  • Discretion of investigator

研究组 & 干预措施

Group- Sensor 1

Experimental

All subjects are enrolled into the test group and receive the Rainbow adhesive adult/pediatric sensors.

干预措施: Rainbow adhesive adult/pediatric sensor (Device)

Group- Sensor 2

Experimental

All subjects are enrolled into the test group and receive the Rainbow adhesive adult/neonatal sensors.

干预措施: Rainbow adhesive adult/neonatal sensor (Device)

结局指标

主要结局

Accuracy of Noninvasive Sensors by Arms Calculation

时间窗: 1-5 hours

Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value. The accuracy results from both sensors will be assessed for equivalence

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Comparison of Noninvasive Hemoglobin Disposable... | 临床试验